Randomized Phase II Trial of Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-Risk Germ Cell Tumors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin (Primary) ; Ifosfamide (Primary) ; Paclitaxel (Primary) ; Bleomycin; Etoposide; Mesna
- Indications Germ cell and embryonal neoplasms
- Focus Therapeutic Use
- 02 Jul 2021 Biomarkers information updated
- 27 Jun 2013 New trial record